Kevin M. Byrne

989 total citations
25 papers, 818 citations indexed

About

Kevin M. Byrne is a scholar working on Pharmacology, Molecular Biology and Toxicology. According to data from OpenAlex, Kevin M. Byrne has authored 25 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 16 papers in Molecular Biology and 7 papers in Toxicology. Recurrent topics in Kevin M. Byrne's work include Microbial Natural Products and Biosynthesis (17 papers), Bioactive Compounds and Antitumor Agents (7 papers) and RNA and protein synthesis mechanisms (6 papers). Kevin M. Byrne is often cited by papers focused on Microbial Natural Products and Biosynthesis (17 papers), Bioactive Compounds and Antitumor Agents (7 papers) and RNA and protein synthesis mechanisms (6 papers). Kevin M. Byrne collaborates with scholars based in United States, Spain and Japan. Kevin M. Byrne's co-authors include Gerald F. Bills, Richard White, Mary Nallin-Omstead, Ramesh C. Pandey, John G. Ondeyka, James D. Bergstrom, Claude Dufresne, Ronald M. Stroshane, Deborah L. Zink and Sheo B. Singh and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Annual Review of Microbiology.

In The Last Decade

Kevin M. Byrne

25 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin M. Byrne United States 19 446 391 257 154 81 25 818
MARIANNA JACKSON United Kingdom 17 591 1.3× 584 1.5× 370 1.4× 153 1.0× 100 1.2× 34 1.0k
Eiji Higashide Japan 17 464 1.0× 497 1.3× 305 1.2× 146 0.9× 114 1.4× 58 938
Yong-Pil Kim Japan 21 420 0.9× 459 1.2× 330 1.3× 180 1.2× 121 1.5× 34 1.1k
Masaji Sezaki Japan 19 456 1.0× 373 1.0× 407 1.6× 192 1.2× 50 0.6× 35 847
TARO NIIDA United Kingdom 19 427 1.0× 525 1.3× 412 1.6× 114 0.7× 118 1.5× 48 917
Brigitte Schlegel Germany 22 496 1.1× 608 1.6× 222 0.9× 128 0.8× 168 2.1× 47 1.2k
SHOJI OMOTO United Kingdom 19 309 0.7× 439 1.1× 304 1.2× 110 0.7× 84 1.0× 57 809
James P. Karwowski United Kingdom 15 309 0.7× 273 0.7× 228 0.9× 100 0.6× 36 0.4× 25 601
TAKASHI SHOMURA United Kingdom 20 556 1.2× 622 1.6× 397 1.5× 212 1.4× 195 2.4× 71 1.2k
K. Eckardt Germany 16 395 0.9× 370 0.9× 307 1.2× 118 0.8× 83 1.0× 74 727

Countries citing papers authored by Kevin M. Byrne

Since Specialization
Citations

This map shows the geographic impact of Kevin M. Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin M. Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin M. Byrne more than expected).

Fields of papers citing papers by Kevin M. Byrne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin M. Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin M. Byrne. The network helps show where Kevin M. Byrne may publish in the future.

Co-authorship network of co-authors of Kevin M. Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin M. Byrne. A scholar is included among the top collaborators of Kevin M. Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin M. Byrne. Kevin M. Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jayasuriya, Hiranthi, Deborah L. Zink, Ángela Basilio, et al.. (2009). Discovery and antibacterial activity of glabramycin A–C from Neosartorya glabra by an antisense strategy. The Journal of Antibiotics. 62(5). 265–269. 25 indexed citations
2.
Zhang, Chaowei, John G. Ondeyka, Deborah L. Zink, et al.. (2009). Discovery of okilactomycin and congeners from Streptomyces scabrisporus by antisense differential sensitivity assay targeting ribosomal protein S4. The Journal of Antibiotics. 62(2). 55–61. 24 indexed citations
3.
Zhang, Chaowei, John G. Ondeyka, Deborah L. Zink, et al.. (2008). Isolation, structure and antibacterial activity of pleosporone from a pleosporalean ascomycete discovered by using antisense strategy. Bioorganic & Medicinal Chemistry. 17(6). 2162–2166. 25 indexed citations
4.
Singh, Sheo B., Deborah L. Zink, Karen Dorso, et al.. (2008). Isolation, Structure, and Antibacterial Activities of Lucensimycins D−G, Discovered from Streptomyces lucensis MA7349 Using an Antisense Strategy. Journal of Natural Products. 72(3). 345–352. 28 indexed citations
5.
Ondeyka, John G., Deborah L. Zink, Ángela Basilio, et al.. (2007). Coniothyrione, a Chlorocyclopentandienylbenzopyrone as a Bacterial Protein Synthesis Inhibitor Discovered by Antisense Technology. Journal of Natural Products. 70(4). 668–670. 36 indexed citations
6.
Byrne, Kevin M., Scott K. Smith, & John G. Ondeyka. (2002). Biosynthesis of Nodulisporic Acid A:  Precursor Studies. Journal of the American Chemical Society. 124(24). 7055–7060. 50 indexed citations
7.
Ondeyka, John G., Kevin M. Byrne, Deborah L. Zink, et al.. (2002). Nodulisporic Acids C, C1, and C2:  A Series of D-Ring-Opened Nodulisporic Acids from the Fungus Nodulisporium sp.. Journal of Natural Products. 66(1). 121–124. 20 indexed citations
8.
Junker, Beth, et al.. (1998). Secondary metabolite scale-up to minimize homolog impurity levels. Biotechnology and Bioengineering. 59(5). 595–604. 7 indexed citations
9.
Junker, Beth, et al.. (1998). Use of soybean oil and ammonium sulfate additions to optimize secondary metabolite production. Biotechnology and Bioengineering. 60(5). 580–588. 28 indexed citations
10.
Bergstrom, James D., Claude Dufresne, Gerald F. Bills, Mary Nallin-Omstead, & Kevin M. Byrne. (1995). DISCOVERY, BIOSYNTHESIS, AND MECHANISM OF ACTION OF THE ZARAGOZIC ACIDS: Potent Inhibitors of Squalene Synthase. Annual Review of Microbiology. 49(1). 607–639. 123 indexed citations
11.
Bills, Gerald F., Fernando Peláez, Jon D. Polishook, et al.. (1994). Distribution of zaragozic acids (squalestatins) among filamentous ascomycetes. Mycological Research. 98(7). 733–739. 33 indexed citations
12.
Byrne, Kevin M., Byron H. Arison, Mary Nallin-Omstead, & Louis A. Kaplan. (1993). Biosynthesis of the zaragozic acids. 1. Zaragozic acid A. The Journal of Organic Chemistry. 58(5). 1019–1024. 20 indexed citations
13.
Nielsen, Jennifer, Ming Jo Hsu, Kevin M. Byrne, & Louis A. Kaplan. (1991). Biosynthesis of the immunosuppressant immunomycin: the enzymology of pipecolate incorporation. Biochemistry. 30(23). 5789–5796. 36 indexed citations
14.
Byrne, Kevin M. & Michael Greenstein. (1986). Nitrogen repression of gilvocarcin V production in Streptomyces arenae 2064.. The Journal of Antibiotics. 39(4). 594–600. 5 indexed citations
15.
Byrne, Kevin M., et al.. (1985). Biosynthesis of fredericamycin A, a new antitumor antibiotic. Biochemistry. 24(2). 478–486. 32 indexed citations
16.
Byrne, Kevin M., et al.. (1985). Largomycin FII chromophore component 4, a new pluramycin antibiotic.. The Journal of Antibiotics. 38(8). 1040–1049. 17 indexed citations
17.
Byrne, Kevin M., et al.. (1984). Structure and properties of major largomycin FII chromophore components.. The Journal of Antibiotics. 37(11). 1344–1356. 9 indexed citations
18.
Chan, James A., Peter P. Roller, Ulrich Weiß, et al.. (1982). Detection of gilvocarcin antitumor complex by a biochemical induction assay (BIA).. The Journal of Antibiotics. 35(4). 529–532. 27 indexed citations
19.
Pandey, Ramesh C., Margaret W. Toussaint, Ronald M. Stroshane, et al.. (1981). Fredericamycin A a new antitumor antibiotic. I. Production, isolation and physicochemical properties.. The Journal of Antibiotics. 34(11). 1389–1401. 97 indexed citations
20.
Byrne, Kevin M., et al.. (1977). Separation of gentamicin C-complex into five components by Craig distribution. Journal of Chromatography A. 131. 191–203. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MARIANNA JACKSON Breakdown of academic impact, for papers by Eiji Higashide Breakdown of academic impact, for papers by Yong-Pil Kim Breakdown of academic impact, for papers by Masaji Sezaki Breakdown of academic impact, for papers by TARO NIIDA Breakdown of academic impact, for papers by Brigitte Schlegel Breakdown of academic impact, for papers by SHOJI OMOTO Breakdown of academic impact, for papers by James P. Karwowski Breakdown of academic impact, for papers by TAKASHI SHOMURA Breakdown of academic impact, for papers by K. Eckardt
Rankless by CCL
2026